The implications of pharmacogenomics in oncology
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tabriz University of Medical Sciences
2023-05-01
|
| Series: | BioImpacts |
| Online Access: | https://bi.tbzmed.ac.ir/PDF/bi-13-181.pdf |
| _version_ | 1797815386605879296 |
|---|---|
| author | Jean J. Latimer |
| author_facet | Jean J. Latimer |
| author_sort | Jean J. Latimer |
| collection | DOAJ |
| first_indexed | 2024-03-13T08:21:54Z |
| format | Article |
| id | doaj.art-ac7d4dcb171a4ac19ced40f4729b5cd5 |
| institution | Directory Open Access Journal |
| issn | 2228-5660 2228-5652 |
| language | English |
| last_indexed | 2024-03-13T08:21:54Z |
| publishDate | 2023-05-01 |
| publisher | Tabriz University of Medical Sciences |
| record_format | Article |
| series | BioImpacts |
| spelling | doaj.art-ac7d4dcb171a4ac19ced40f4729b5cd52023-05-31T07:51:23ZengTabriz University of Medical SciencesBioImpacts2228-56602228-56522023-05-0113318118210.34172/bi.2023.27686bi-27686The implications of pharmacogenomics in oncologyJean J. Latimer0Department of Pharmaceutical Sciences and AutoNation Institute for Breast Cancer Research and Care, Barry & Judy Silverman College of Pharmacy, Nova Southeastern University, FL, USAhttps://bi.tbzmed.ac.ir/PDF/bi-13-181.pdf |
| spellingShingle | Jean J. Latimer The implications of pharmacogenomics in oncology BioImpacts |
| title | The implications of pharmacogenomics in oncology |
| title_full | The implications of pharmacogenomics in oncology |
| title_fullStr | The implications of pharmacogenomics in oncology |
| title_full_unstemmed | The implications of pharmacogenomics in oncology |
| title_short | The implications of pharmacogenomics in oncology |
| title_sort | implications of pharmacogenomics in oncology |
| url | https://bi.tbzmed.ac.ir/PDF/bi-13-181.pdf |
| work_keys_str_mv | AT jeanjlatimer theimplicationsofpharmacogenomicsinoncology AT jeanjlatimer implicationsofpharmacogenomicsinoncology |